Rosen Law Firm is investigating potential securities claims against Anavex Life Sciences (AVXL) after the company disclosed in a May 6, 2026 Form 8-K that CEO Christopher Missling was terminated for cause. The law firm alleges Anavex may have issued materially misleading business information and is preparing a class action to recover investor losses.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
